Kevin leveraged his substantive understanding of intellectual property issues to help one medical device company build a portfolio of more than 150 domestic and foreign patents and applications that protects the client’s pioneering technology for a new generation of implantable drug delivery and biosensing devices. He has helped guide patent strategy in matters ranging from protecting a novel urological drug delivery device platform to providing patent clearance opinions for several different cardiovascular medical technologies. Kevin also successfully challenged a number of competitor patents for his clients through U.S. Patent and Trademark Office re-examination proceedings.
Undertook IP due diligence and freedom-to-operate analysis for a medical device company in its $22 million purchase of a cardiovascular products company.
Helped a client build a portfolio of 150 patents to protect a pioneering implantable medical device.
Represented a university in patenting innovations in microneedles for ocular and transdermal drug delivery.
Awards and Rankings
Recognized as “Lawyer of the Year” by The Best Lawyers in America in the area of biotechnology law (2017)
Named to The Best Lawyers in America in the area of patent law (2013-2019) and biotechnology law (2015-2019)
Selected for inclusion in Georgia Super Lawyers “Rising Stars” (2005-2006)
Selected for inclusion in IP Stars by Managing Intellectual Property (2013, 2018)
“Much of my work is with start-up companies and universities that are developing new innovations in the medical technology field.”
Legal Alert: A Little Rule With Big Implications: USPTO Implements New Fee Schedule Including a 75% Reduction in Patent Fees for Applicants Qualifying for Micro Entity Status (March 28, 2013)
On March 19, 2013, the United States Patent and Trademark Office (USPTO) implemented a new fee schedule as authorized by the Leahy-Smith America Invents Act (Act). Among numerous changes in the fees ...
Legal Alert: Federal Circuit Holds Contribution of Patent Claim Element Insufficient to Trigger Co-Inventorship (March 16, 2009)
Legal Alert: Patent Term Adjustment Determinations May Be Affected Following District Court Decision (October 30, 2008)
Legal Alert: U.S. Patent Office Issues Final Rule on Ex Parte Patent Appeals (June 16, 2008)
Legal Alert: Tafas v. Dudas: Court Declares USPTO Patent Examination Rule Changes Null and Void (April 3, 2008)
Legal Alert: U.S. District Court Enjoins Implementation of New Patent Rule Changes (November 2, 2007)
Legal Alert: Patent Examination Guidelines and New Rules Update (October 17, 2007)
Legal Alert: The U.S. Patent and Trademark Office Revises Its Rules on Continued Examination Filings, Patentably Indistinct Claims, and Examination of Claims (August 23, 2007)
Maximizing Patent Damages: Provisional Rights And Marking (July 18, 2017)
To justify the substantial effort and expense required to enforce a patent, a patentee often needs to be able to collect damages for past infringement. That is, obtaining a prospective injunction ...
2007 Intellectual Property -- Topics for Corporate Lawyers (2007) (2007)
26th Annual Business Law Institute
Use of Incorporation By Reference in Patents (March 2007)
Reprinted with permission Law Journal Newsletters - Patent Strategy & Management
Hot Topics in the Medical Device Industry (February 19, 2013)
SEMDA Annual Conference
Sutherland Partner Kevin W. King is speaking at the Southeastern Medical Device Association (SEMDA) 2013 Annual Conference on February 19, 2013 in Atlanta, Georgia. Kevin will participate in a panel ...
SEMDA 2010 Investor Conference (March 25, 2010)
Hot Topics in Patent Procurement and IP Strategy (March 13, 2008)
SEMDA 2008 Investor Conference
Sutherland Partner Kevin W. King is speaking at the Southeastern Medical Device Association (SEMDA) 2008 Investor Conference on Thursday, March 13, 2008, in Atlanta, Georgia. Kevin's presentation ...
Member, Intellectual Property Law Section, American Bar Association
Member, Intellectual Property Law Section, State Bar of Georgia
Member, Georgia Biotechnology Industry Organization (GaBio)
You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The Internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.